Inventor · disambiguated record
Vijay Peddareddigari
Also filed as: PEDDAREDDIGARI VIJAY · PEDDAREDDIGARI VIJAY GOPAL RED · PEDDAREDDIGARI VIJAY GOPAL REDDY
3 granted patents·12 pending applications·6 citations·filing 2002–2025
59Inventor score
Top patents by PatentIndex Score
15 records- 0175US12269860B2Compositions and methods comprising engineered chimeric antigen receptor and modulator of CARAUTOLUS LTD·Filed 2022·Granted Apr 8, 2025·0 cites·5 claims
- 0275US11591613B2Retroviral and lentiviral vectorsAUTOLUS LTD·Filed 2017·Granted Feb 28, 2023·1 cites·7 claims
- 0369US2025296976A1Compositions and methods comprising engineered chimeric antigen receptor and modulator of carAUTOLUS LTD·Filed 2025·Application pending·0 cites
- 0468US2024093232A1Retroviral And Lentiviral VectorsAUTOLUS LTD·Filed 2023·Application pending·0 cites
- 0565US2024228959A9Large scale car-t immune cell manufacturing method utilizing lentiviral vector transfectionKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 0662US2022145325A1Compositions and methods comprising engineered chimeric antigen receptor and modulator of carAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 0755US2025090579A1Dnvsig3 and dnvsig8 receptors and methods of using the sameKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 0855US2023190809A1Alternative generation of allogeneic human t cellsTMUNITY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0949US7407672B2Composition derived from biological materials and method of use and preparationNAT HEART CT·Filed 2002·Granted Aug 5, 2008·5 cites·46 claims
- 1045US2021130775A1Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressedAUTOLUS LTD·Filed 2018·Application pending·0 cites
- 1145US2020239545A1ReceptorAUTOLUS LTD·Filed 2018·Application pending·0 cites
- 1245US2022257757A1Method for preconditioning a subject who is about to receive a t-cell therapyAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 1343US2022089724A1Treatment of neurotoxicity and/or cytokine release syndromeAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 1436US2019352409A1Chimeric antigen receptorAUTOLUS LTD·Filed 2017·Application pending·0 cites
- 1530US2016263116A1CombinationsGLAXOSMITHKLINE LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vijay Peddareddigari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →